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Summary
Objective: To analyze the possible influence of antibiotic treatment on the results of
different diagnostic tests for the diagnosis of lower respiratory tract infections with
Streptococcus pneumoniae.
Material and methods: A prospective cohort of 159 unselected adult immunocom-
petent patients admitted to Silkeborg County Hospital in Denmark with community-
acquired lower respiratory tract infections underwent microbiological investigations
with fiber-optic bronchoscopy with bronchoalveolar lavage, blood and sputum culture
and urine antigen test for type-specific polysaccharide capsular antigens of S.
pneumoniae.
Results: When stratified for antibiotic treatment prior to microbiological sampling,
three different groups of patients with documented or probable infection with S.
pneumoniae could be identified. The first group comprised 14 patients who were
culture positive in one or more culture tests, where most (11/14) did not receive any
antibiotic treatment within 24 hours of sampling. The second group consisted of nine
patients with a positive urine antigen test where 8/9 and 9/9 received antibiotic
treatment 24 and 48 hours, respectively, prior to urine sampling. Only a single patient
was positive in both systems, making a total of 22 patients with documented
pneumococcal infection. As a positive culture test was dependent on the absence
of antibiotic treatment, whereas a positive urine antigen test depended on antibiotic
treatment within 48 hours, the two tests were complementary in the diagnosis of
infection with S. pneumoniae. The third group of patients with probable pneumo-
coccal infection were identified as 26% and 20% of the remaining 137 patients with* Corresponding author. Tel.: +45 87 22 23 60; fax: +45 86 80 24 40.
E-mail address: j.korsgaard@dadlnet.dk (J. Korsgaard).
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Infectionwith Streptococcus pneumoniae is themost
frequently reported etiology in lower respiratory
tract infections (LRTI) with frequencies from 29%1
to as high as 48% in a recent British survey.2 The
diagnostic approach in pneumococcal disease is dif-
ficult, as blood culture is very specific but lacks
sensitivity, and sputum culture may represent colo-
nization as 30—70% of adults with chronic obstructive
pulmonary disease are colonized with Streptococcus
pneumoniae.3 More invasive investigations with
fiberoptic bronchoscopy improve the diagnostic yield
but seem only justified as a routine diagnostic pro-
cedure in patients with severe disease.4 Further-
more, the prior administration of antibiotic
treatment before sampling bacteriological material
clearly reduces the frequency of culture of pneumo-
cocci. For example, 42% of patients with severe
community-acquired pneumonia without prior anti-
biotic treatmentbecameculture positive, in contrast
toonly 15%ofpatients treatedwith antibioticsbefore
microbiological sampling.5
This difficulty in the diagnosis of pneumococcal
infection is one of the reasons for the assumption6
that it is the most frequent etiology, even among
patients with no etiologic diagnosis despite compre-
hensive microbiological sampling. It is also the rea-
son for the continued search for new and better
diagnostic methods in pneumococcal disease.
Among the latter are several methods to detect
either type-specific polysaccharide capsular anti-
gens (PCA) or to detect C-polysaccharide from the
pneumococcal cell wall. These antigens can be
detected in sputum, blood or urine samples. These
methods have been tested in several investigations,
where results show a generally high (above 90%)
diagnostic specificity, but diagnostic sensitivity is
variable and often low, so that half or more ofpatients with proven pneumococcal disease by cul-
ture remain negative for urine antigen.7 Thus no
antigen detection tests have proved to be suffi-
ciently effective to gain a place in the routine
diagnosis of respiratory infection.8,9
This study was designed to validate culture for S.
pneumoniae and urine antigen detection of capsular
antigens in adult patients admitted to hospital with
lower respiratory tract infection in relation to the
administration of antibiotic treatment prior to
microbiological sampling.Material and methods
A total of 159 immunocompetent unselected adult
patients admitted to Silkeborg County Hospital in
Denmark from 1 September 1997 to 1 September
2000 with lower respiratory tract infections were
consecutively included in the study, while eight
patients fulfilling the inclusion criteria declined
participation. The clinical diagnosis of LRTI required
that the patient had fever (rectal temperature
37.6 8C within 48 hours of inclusion in the study)
and/or an increased leucocyte count (11  109/l)
in peripheral blood on admission as signs of inflam-
mation, together with increased focal symptoms
from the lower airways with at least one of three
newly developed symptoms of increased dyspnoea,
increased coughing and/or increased sputum puru-
lence.10 Of the 159 patients diagnosed with lower
respiratory tract infections 89 (56%) appeared with a
new infiltrate on their chest X-ray on admission,
while 70 were without new infiltrates. All patients
were admitted with community-acquired infection
and were investigated within 24 hours of admission.
Patients with known malignancy and patients
with an oxygen saturation below 85% with a max-
imum of 1 litre nasal oxygen prior to possibleunknown or known non-pneumococcal etiology, respectively, who received recent
antibiotic treatment within 2—4 weeks of diagnostic sampling. By comparison, 0%
( p < 0.01) with documented pneumococcal infection received antibiotic treatment
in weeks 2—4 prior tomicrobiological sampling. As such a further eight patients should
be expected to have infection with S. pneumoniae but would test negative in both
culture tests and the urine antigen test because of antibiotic treatment within weeks
2—4 prior to sampling.
Conclusion: The diagnosis of infection with S. pneumoniae is very dependent on
whether or not recent (within 2—4 weeks) or immediate (within 48 hours) antibiotic
treatment has been given prior to microbiological sampling of patients. The results
suggest an optimized diagnostic strategy with, if possible, sampling for culture prior
to antibiotic treatment, while sampling for pneumococcal antigens should wait 24—
48 hours for antibiotic treatment.
# 2005 International Society for Infectious Diseases. Published by Elsevier Ltd. All
rights reserved.
276 J. Korsgaard et al.bronchoscopy were excluded. No record was kept of
the number of patients excluded.
There were no restrictions with regard to the
prior administration of antibiotic treatment, but
for all patients included, very detailed information
on prior antibiotic treatment for any diagnosis was
obtained from either the patient or, if necessary, by
contact with the patient’s general practitioner.
Information on single doses and type of antibiotic
treatment on individual treatment days was
obtained for the 28 days prior to hospital admission
and the microbiological sampling.
All included patients underwent a standardized
diagnostic procedure with fiberoptic bronchoscopy
with bronchoalveolar lavage (BAL), blood and spu-
tum culture and urine antigen tests.
BAL fluid was received by the department of
clinical microbiology and culture started within a
maximum of six hours from sampling. The fluid was
cultured for bacteria on 5% blood agar with semi-
quantitative determinations by dispersion of 1 and
10 ml on each half of the plate. Consequently the
sensitivity of bacterial culture was 100 colony
forming units (CFU) per ml.
Urine samples were sent immediately by mail
(room temperature) to Statens Seruminstitut in
Copenhagen and were received within 24 hours of
sampling. The presence of pneumococcal urine anti-
gens was analyzed by countercurrent immuno-elec-
trophoresis to detect type-specific pneumococcal
capsular polysaccharides.11
The study was performed according to the
Declaration of Helsinki II and approved by the local
ethical committee and all participating patients
gave written consent.Figure 1 The frequency of antibiotic treatment in four
different time periods prior to microbiological sampling in
three different groups of adult patients diagnosed with
either pneumococcal infection (n = 22), known infection
with other etiology than Streptococcus pneumoniae
(n = 61) and unknown etiology (n = 76) despite intensive
microbiological investigations. The frequency of antibio-
tic treatment in patients diagnosed with pneumococcal
infection was lower ( p < 0.01) than in the two other
groups.Results
A total of 22 patients were positive in one or more
tests for a diagnosis of LRTI due to S. pneumoniae
(Table 1). When analyzed according to antibiotic
treatment within 28 days prior to microbiological
sampling, three different groups of patients with
documented or probable infection with S. pneumo-
niae infection could be identified. Detailed results
on other etiologies among the patients will be pub-
lished separately.
The first group (Table 1) contained 14 patients
(excluding two patients (numbers 142 and 146) who
were culture positive by blood culture obtained
before administration of the first dose of antibiotic
treatment) who were culture positive in one or more
tests, where most (11/14) did not receive any anti-
biotic treatment within 24 hours of sampling. Most
patients were diagnosed by BAL culture (tenpatients) while an additional three patients were
positive by blood culture and an additional patient
was positive only by sputum culture.
The second group (Table 1) comprised nine
patients diagnosed with a positive urine antigen
test, where 8/9 and 9/9 received antibiotic treat-
ment within 24 and 48 hours, respectively, prior to
urine sampling. When analyzed according to anti-
biotic treatment within the last 24 hours prior to
urine sampling, the numbers positive by their anti-
gen assay were 8/10 with antibiotic treatment com-
pared to 1/12 without antibiotic treatment within
24 hours of urine sampling ( p = 0.002, Fischer’s
exact test).
When comparing groups 1 and 2, the two separate
diagnostic systems were complementary, with only
1/22 patients having both a positive culture test
(blood culture) and a positive urine antigen test.
Thus a positive culture test was associated with the
absence of recent antibiotic treatment, while a
positive urine antigen test was associated with
immediate (within 48 hours) prior antibiotic treat-
ment.
A third group of patients with probable but not
documented infection with S. pneumoniaewas iden-
tified as 26% and 20% of the remaining 137 patients
with unknown or known non-pneumococcal etiology,
respectively did receive recent (within day eight to
day 28) antibiotic treatment prior to sampling. By
comparison, 0% (p < 0.01) of patients with docu-
mented infection with S. pneumoniae received anti-
biotic treatment within 2—4 weeks of sampling
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Table 1 Detailed information on 22 of 159 adult patients who tested positive in one or more tests for pneumococcal lower respiratory tract infection.
Patient id 24 35 13 2 10 88 115 158 80 117 8 104 27 19 21 38 46 106 127 142 146 147
Antibiotics
24 hours
0 0 0 0 0 0 0 0 2 (e) 4 (c) 0 0 0 2 (a) 0 2 (a) 2 (a) 2 (b) 2 (a) 3 (a) 2 (a+d) 2 (a)
Antibiotics
day 2—3
0 0 0 0 0 0 0 1 (a) 0 0 0 0 0 0 6 (e) 6 (b) 6 (a) 0 0 1 (a) 1 (a+d) 0
Antibiotics
day 4—7
0 0 0 0 0 0 0 4 (a) 0 0 0 0 0 0 0 3 (b) 0 0 0 0 0 0
Antibiotics
week 2—4
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Infiltrate
chest X-ray
No Yes Yes Yes No No No Yes Yes Yes Yes Yes Yes Yes No Yes Yes Yes Yes Yes Yes Yes
BAL culture
S. pneum.
(cfu/ml)
104 (2) 104 (2) 103 (2) 104 (2) 105 (2) 105 (2) 106 (2) 103 (2) 102 (2) 105 (2) — — — — — — — — — — — —
Blood culture
S. pneum.
— — — — — — — + — — + (2) + (2) — + (2) — — — — — +a (2) +a (2) —
Sputum culture
S. pneum.
— n.o. n.o. + + n.o. n.o. n.o. n.o. n.o. n.o. n.o. + (2) — — — n.o. n.o. n.o. n.o. n.o. n.o.
Urine
pneumococcal
antigen
(capsule type)
— — — — — — — n.o. — — — — — + (1) + (19F) + (1) + (1) + (1) + (8) + (8) + (1) + (1)
The information on antibiotics refers to number of times that antibiotics were given to a patient in the given time interval. The sensitivity to benzylpenicillin of the isolated strains of
pneumococci was graduated from 0 = resistant, 1 = reduced sensitivity and 2 = fully sensitive. All 19 strains were fully sensitive to benzylpenicillin. The types of antibiotics given were
a = benzylpenicillin (intravenous), b = phenoxymethylpenicillin (oral), c = ampicillin (intravenous), d = aminoglycocides (intravenous) and e = macrolides (oral).
a Blood sample for culture taken before antibiotics were given; n.o. = sputum not obtainable.
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of recent antibiotic treatment is equal among the
different groups of patients with known or unknown
etiologies, statistically a third group of eight
patients [8/(22 + 8) = 26% which corresponds to
the percentage of patients with known non-pneu-
mococcal etiology and to the percentage of patients
with unknown etiology who received antibiotic
treatment in weeks 2—4 prior to microbiological
sampling (Figure 1)] should be expected in the study
population to have infection with S. pneumoniae but
test negative in both culture and urine antigen tests
because of recent antibiotic therapy.
All the 19 individual strains of S. pneumoniae
diagnosed by culture (Table 1) were fully sensitive
to benzylpenicillin. Among the nine patients with a
positive urine antigen test, six were diagnosed with
capsule type 1, two patients were diagnosed with
type 8 and one patient had capsule type 19F.
Altogether the frequency of infection with S.
pneumoniae in this prospective cohort of unselected
adult patients admitted to hospital with LRTI is
estimated to be 14 (culture positive) plus nine (urine
antigen positive) plus eight (negative in both tests
because of recent antibiotic treatment) which adds
up to a calculated true frequency of 30/159 or 19%.Discussion
Despite intensive diagnostic efforts at hospitaliza-
tion, previous studies on the etiology of LRTI have
found that in 50% or more of patients no etiology can
be identified. The reason for the low diagnostic
sensitivity is not clear, but may be due to problems
with the diagnostic methodology or the existence of
currently unknown etiologies.12
In a prediction model6 where the clinical char-
acteristics of patients with known pathogens were
compared to the characteristics of patients where
the etiology remained unknown, most of the
unknown cases were predicted to be caused by S.
pneumoniae. In fact, the major difference between
patients with pneumococcal and undetermined
etiology was the frequency of antibiotic treatment
before hospital admission.
The marked reduction in microbiological diagnos-
tic sensitivity with prior antibiotic treatment is well
documented4,5,13—15 and is perhaps most critical for
the culture of S. pneumoniae as16 significantly fewer
(2/79) patients were diagnosed with pneumococcal
infection than with other pathogens (18/83) where
antibiotic treatment was given before admission.
These results confirm the critical influence of
prior antibiotic treatment on the culture of S.
pneumoniae, as only 3/14 patients culture positivefor S. pneumoniae received antibiotic treatment
within 24 hours of sampling. Moreover, the results
suggest that antibiotic treatment given 2—4 weeks
prior to sampling for culture precludes the growth of
S. pneumoniae from patient specimens.
To improve diagnostic sensitivity several differ-
ent tests to detect pneumococcal PCA have been
developed. In a recent British survey2 which
included PCA detection in urine and sputum as part
of a wide range of different microbiological inves-
tigations, an etiologic diagnosis was made in 75% of
patients, and of these S. pneumoniaewas diagnosed
as the etiologic agent in 129/267 patients. Among
the latter patients, the majority (59%) were positive
in one and negative in the other four tests used for
pneumococcal etiology. The proportion of patients
positive by culture was below 20%, while serology
and PCA techniques diagnosed the majority of
patients. The high discrepancy between results of
culture and PCA detection in pneumococcal disease
is a characteristic finding. In a recent Spanish
study17 where 51 patients were diagnosed with
pneumococcal infection by either blood culture
and/or PCA detection in urine, only nine patients
were positive in both tests while 42 were positive in
only one of the two test systems.
In two Swedish studies18,19 also with high discre-
pancy between culture and PCA detection, conflict-
ing results on the effect of prior antibiotic
treatment were reported with either a doubling
of antigen detection after antibiotic treatment18
or significantly lower sensitivity of antigen detec-
tion after antibiotic treatment.19
The present comparison of diagnostic results
obtained by culture or PCA detection in urine speci-
mens demonstrates that the two diagnostic systems
are complementary, with only 1/22 patients diag-
nosed with pneumococcal infection being positive in
both systems. A positive culture was associated with
the absence of both immediate and recent antibio-
tic treatment while a positive antigen detection test
was associated with immediate (within 48 hours)
antibiotic treatment. Both systems seemed to fail
in patients who had received recent (within 2—4
weeks) antibiotic treatment.
The present results suggest that the documented
large discrepancy between antigen detection and
culture of S. pneumoniae could reflect whether or
not antibiotic treatment has been given prior to
bacteriologic sampling.
Antigenuria could reflect the presence of bacter-
aemia with S. pneumoniae or represent antigens
released from the lungs.17,20 The present results
support the latter explanation, where antigenuria
represents antigens released from the lungs follow-
ing initial antibiotic treatment with a presumed high
Antibiotic treatment and the diagnosis of Streptococcus pneumoniae 279rate of bacterial killing, while there is no association
between positive blood culture and antigenuria.
Future studies on the sensitivity of different
diagnostic approaches in pneumococcal airway
infection should include a detailed account of prior
antibiotic treatment, as immediate and recent anti-
biotic treatment have opposite effects on pneumo-
coccal antigen detection, while all antibiotic
treatment prior to microbiological sampling reduces
the frequency of positive culture for S. pneumoniae.
Moreover, the present results suggest that the diag-
nostic strategy for pneumococcal infection can be
improved with sampling for culture prior to anti-
biotic treatment, while urine sampling for pneumo-
coccal antigen should wait 24—48 hours for the
initial bacterial killing by antibiotics.
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